Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Microbiology

Background:

• Hydroxyapatite (HA) is a key biomaterial for bone regeneration.
• Bacterial infections pose a significant challenge for orthopedic implants.
• Silver nanoparticles (AgNPs) exhibit potent antimicrobial activity.

Purpose of the Study:

• To synthesize and characterize silver-substituted nanosize hydroxyapatites (AgHAs).
• To evaluate the antibacterial efficacy of AgHAs against Escherichia coli and Staphylococcus aureus.
• To assess the biocompatibility and osteoblast response to AgHAs for potential bone tissue engineering applications.

Main Methods:

• Microwave processing for AgHA synthesis.
• X-ray diffraction (XRD) and Transmission Electron Microscopy (TEM) for characterization.
• Spread plate and disc diffusion methods for antibacterial testing.
• Osteoblast cell culture assays for biocompatibility assessment.

Main Results:

• Synthesized AgHAs were nanosized (30 nm) with needle-like morphology.
• AgHA demonstrated antibacterial activity against E. coli and S. aureus, even at 0.5% silver.
• Osteoblast attachment was observed on AgHA, with significantly greater spreading on 0.5% AgHA.
• AgHA phase remained stable up to 700°C.

Conclusions:

• Low concentrations of silver substitution in hydroxyapatite (0.5%) effectively inhibit bacterial growth.
• AgHAs show promising biocompatibility and enhance osteoblast cell spreading.
• These findings suggest AgHAs have potential for developing infection-resistant bone regenerative materials with improved osseointegration.